Drugs / Iron III Hydroxide Polymaltose Complex
last change 25 days ago re-read 9 days ago

Iron III Hydroxide Polymaltose Complex

Developed for
anemia · disorder of iron metabolism and transport · iron deficiency anemia · iron metabolism disease
Investigated by
Soroka University Medical Center · University of Medicine, Mandalay

Trials 2

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 42 trials
Phase 4 NCT07391371 Feb → Oct 2026 expected iron deficiency anemia University of Medicine, Mandalay Not yet recruiting No outcome recorded
Phase 4 NCT00479102 May 2007 → ? anemia, disorder of iron metabolism and transport Soroka University Medical Center Unknown No outcome recorded
Comparator or background therapy5 trials
Phase 3 NCT01857011 Comparator Apr 2014 → Apr 2016 iron deficiency anemia Federal University of São Paulo Completed Missed primary
Phase 4 NCT06631612 Comparator Jan 2024 → Jan 2025 overdue iron deficiency anemia Ain Shams University Active not recruiting No outcome recorded
Phase 4 NCT02487719 Comparator Jun 2015 → Jun 2016 iron deficiency anemia, pregnancy disorder University of Zurich Unknown No outcome recorded
— NCT06624709 Comparator Nov 2024 → Sep 2026 overdue — Riccardo Pfister Recruiting No outcome recorded
— NCT06437080 Comparator Oct 2022 → Oct 2025 disorder of iron metabolism and transport, iron metabolism disease Akram Medical Complex Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 8 sources stand behind the page.

FieldValueCited text
Known as iron(III)-hydroxide polymaltose complex “Oral iron(III)-hydroxide polymaltose complex 100 mg twice daily in the fist 8 postoperative weeks.” NCT01857011 ↗
2

NCT07391371 ↗

NCT06437080 ↗

Known as ferric hydroxide polymaltose complex ClinicalTrials.gov intervention name — accepted as the source's own label NCT06631612 ↗
Known as Ferripel-3 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00479102 ↗
Known as Iron polymaltose ClinicalTrials.gov intervention name — accepted as the source's own label NCT02487719 ↗
Known as maltofer “This arm will receive 2-3mg/kg/d of maltofer 4 times a day” NCT06624709 ↗
Route Oral “iron polymaltose complex administered orally” PMID 27068478 ↗ Apr 2016